High rate of regression from micro-macroalbuminuria to normoalbuminuria in children and adolescents with type 1 diabetes treated or not with enalapril: The influence of HDL cholesterol

Diabetes Care

Volumn 34, Issue 2, 2011, Pages 424-429

  Salardi, Silvana ^a   Balsamo, Claudia ^a   Zucchini, Stefano ^a   Maltoni, Giulio ^a   Scipione, Mirella ^a   Rollo, Alessandra ^a   Gualandi, Stefano ^a   Cicognani, Alessandro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ENALAPRIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ALBUMINURIA; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; GROUPS BY AGE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID ANALYSIS; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; MICROALBUMINURIA; OBSERVATIONAL STUDY; PREVALENCE; REMISSION; RETROSPECTIVE STUDY; SCHOOL CHILD; URINARY EXCRETION;

ADOLESCENT; ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHILD; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; ENALAPRIL; FOLLOW-UP STUDIES; HUMANS; HYPERGLYCEMIA; LONGITUDINAL STUDIES; PREVALENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES;

EID: 79951713357     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-1177     Document Type: Article

References (25)

1. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982;1:1430-1432 (Pubitemid 12123979)
2. Mathiesen ER, Oxenbøll B, Johansen K, Svendsen PA, Deckert T. Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 1984;26:406-410 (Pubitemid 14080812)
3. Shield JPH, Hunt LP, Karachaliou F, Karavanaki K, Baum JD. Is microalbuminuria progressive? Arch Dis Child 1995;73:512-514
4. Rudberg S, Dahlquist G. Determinants of progression of microalbuminuria in adolescents with IDDM. Diabetes Care 1996; 19:369-371 (Pubitemid 26115462)
5. Salardi S, Cacciari E. Is microalbuminuria progressive? Arch Dis Child 1996;75: 266
6. ACE Inhibitors in Diabetic Nephropathy Trialist Group. Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data. Ann Intern Med 2001;134:370-379
7. Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS. Regression of microalbuminuria in type 1 diabetes. N Engl J Med 2003;348: 2285-2293 (Pubitemid 36638102)
8. Giorgino F, Laviola L, Cavallo Perin P, Solnica B, Fuller J, Chaturvedi N. Factors associated with progression to macroalbuminuria in microalbuminuric type 1 diabetic patients: the EURODIAB Prospective Complications Study. Diabetologia 2004;47:1020-1028 (Pubitemid 38918161)
9. Bain SC, Gill GV, Dyer PH, et al. Characteristics of type 1 diabetes of over 50 years duration (the Golden Years Cohort). Diabet Med 2003;20:808-811 (Pubitemid 41701500)
10. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD; The Collaborative Study Group. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456-1462 (Pubitemid 23335891)
11. Strippoli GFM, Craig M, Deeks JJ, Schena FP, Craig JC. Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review. BMJ 2004;329:828-838
12. Mauer M, Zinman B, Gardiner R, et al. Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med 2009;361:40-51
13. Rudberg S, Østerby R, Bangstad H-J, Dahlquist G, Persson B. Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with type I (insulin-dependent) diabetes mellitus. Diabetologia 1999;42: 589-595
14. Amin R,Widmer B, Prevost AT, et al. Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study. BMJ 2008;336:697-701 (Pubitemid 351481211)
15. Salardi S, Cacciari E, Pascucci MG, et al. Microalbuminuria in diabetic children and adolescents. Relationship with puberty and growth hormone. Acta Paediatr Scand 1990;79:437-443
16. Donaghue KC, Chiarelli F, Trotta D, Allgrove J, Dahl-Jorgensen K; International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2006-2007. Microvascular and macrovascular complications. Pediatr Diabetes 2007;8:163-170
17. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114(2 Suppl 4th Report): 555-576
18. Cook S, Auinger P, Huang TTK. Growth curves for cardio-metabolic risk factors in children and adolescents. J Pediatr 2009; 155:S6.e15-e26
19. Marcovecchio ML, Dalton RN, Prevost AT, et al. Prevalence of abnormal lipid profiles and the relationship with the development of microalbuminuria in adolescents with type 1 diabetes. Diabetes Care 2009;32:658-663
20. Molitch ME, Steffes M, Sun W, et al; Epidemiology of Diabetes Interventions and Complications Study Group. Development and progression of renal insufficiency in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study. Diabetes Care 2010;33:1536-1543
21. Tolonen N, Forsblom C, Thorn L, et al.; Finn Diane Study Group. Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes. Diabetologia 2009;52:2522-2530
22. Tuomilehto J, Borch-Johnsen K, Molarius A, et al. Incidence of cardiovascular disease in type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland. Diabetologia 1998;41:784-790 (Pubitemid 28313711)
23. Molitch ME, Rupp D, Carnethon M. Higher levels of HDL cholesterol are associated with a decreased likelihood of albuminuria in patients with long-standing type 1 diabetes. Diabetes Care 2006; 29:78-82 (Pubitemid 44033435)
24. Bu X, Warden CH, Xia YR, et al. Linkage analysis of the genetic determinants of high density lipoprotein concentrations and composition: evidence for involvement of the apolipoprotein A-II and cholesteryl ester transfer protein loci. Hum Genet 1994;93:639-648 (Pubitemid 24166489)
25. Belalcazar LM, Reboussin DM, Haffner SM, et al.; Look AHEAD (Action for Health in Diabetes) Obesity, Inflammation, and Thrombosis Research Group. Marine ω-3 fatty acid intake: associations with cardiometabolic risk and response to weight loss intervention in the Look AHEAD (Action for Health in Diabetes) study. Diabetes Care 2010;33:197-199